@prefix this: <http://purl.org/np/RAmfsNOz5lUf7LZDYaKjoAW7vebVUo2_P6FYnWnERj5d0> .
@prefix sub: <http://purl.org/np/RAmfsNOz5lUf7LZDYaKjoAW7vebVUo2_P6FYnWnERj5d0#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_8504> bl:category bl:Disease .
  
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_8504>;
    rdf:predicate bl:treats;
    rdf:subject <https://identifiers.org/drugbank:DB01256>;
    a rdf:Statement;
    rdfs:label "altabax r 2 staphylococcus aureus streptococcus pyogenes see clinical studies 14 to reduce the development of drug resistant bacteria and maintain the effectiveness of altabax and other antibacterial drugs altabax should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria altabax a pleuromutilin antibacterial is indicated for the topical treatment of impetigo due to staphylococcus aureus streptococcus pyogenes 1";
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    bl:provided_by <https://w3id.org/um/NeuroDKG>;
    bl:relation schema:TreatmentIndication .
  
  <https://identifiers.org/drugbank:DB01256> bl:category bl:Drug .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "FWpkfky/UV/LRl1rf5Iaqj0G/dXDDPgdefVnNOhYzLFyEEIpllMOgnjwNjQ2vdgEBMOQ4rzDIZLQhJcth/WBv6+ejXVNKmBbXqqKdLcO9XGDlqb+cAgWrSFLNHNLk/ANzNK4+qMAkM7nhmVE1rS7HAeYrCGyebQaSWLw7BKH9rY=";
    npx:hasSignatureTarget this: .
  
  this: dct:created "2021-06-15T18:22:21.352+02:00"^^xsd:dateTime;
    dct:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}